This is a phase II, randomised trial of combination chemotherapy with bevacizumab for patients with high risk but surgically resectable cancer of the rectum to be recruited by multiple UK sites

Update Il y a 4 ans
Reference: EUCTR2010-022754-17

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The principal research question is to see how effective the two different treatment arms are. Efficacy will be measured by examining tissue removed at surgery to see how many patients have a pathological complete response; that is - how many patients do not have any visible tumour left, even when looking through a microscope.


Inclusion criteria

  • Locally advanced rectal cancer

Links